The choice you make today can help fuel the cures of tomorrow.
The choice you make today can help fuel the cures of tomorrow.
“You have cancer.” The words strike fear into the hearts of millions each year. Learning someone we love has cancer can tear at our hearts.
But at Baylor College of Medicine, we’re working toward a day when no one will have to fear cancer again. .
Baylor College of Medicine is one of just three National Cancer Institute-designated Comprehensive Cancer Centers in Texas. That’s recognition of the fact that we are leading the way to one key breakthrough after another.
For example, our researchers recently took part in a multi-institutional collaboration that could point the way to more effective, personalized treatments for meningioma patients.
Meningiomas are the most common type of tumor originating in the brain. Currently, surgery and radiotherapy represent the most effective treatments, but it has been difficult to foresee how each patient will respond to these treatments.
Now, our researchers have identified a genetic biomarker with the potential to predict a meningioma patient’s response to radiation before treatment even begins.
“This study will help clinicians predict how patients with each meningioma subtype respond to treatments with great accuracy,” says Tiemo Klisch, Ph.D., assistant professor of Molecular and Human Genetics at Baylor.
“We are thankful to the patients and their families who participated in this research,” adds study author Akash Patel, M.D., a neurosurgeon and associate professor of Neurosurgery at Baylor.
You see, it isn’t only our doctors who are driving breakthroughs. It’s people like you. .
Only research can lead to a cure. And research doesn’t happen without funding. .